GMK-PRIMARY FEMUR STD CEMENTED SIZE 3 R
Report
- Report Number
- 3005180920-2023-00987
- Event Type
- Injury
- Date Received
- December 7, 2023
- Date of Event
- November 13, 2023
- Report Date
- December 6, 2023
- Manufacturer
- MEDACTA INTERNATIONAL SA
- Product Code
- JWH
- UDI-DI
- 07630040720243
- PMA / PMN Number
- K173794
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- 003
Narratives
BATCH REVIEW PERFORMED ON 16-NOV-2023 LOT 111212: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 08-AUG-2011. EXPIRATION DATE: 2016-06-30. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, ALL ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED CASE DURING THE PERIOD OF THE REVIEW. ADDITIONAL ITEMS INVOLVED IN THE COMPLAINTS, BATCH REVIEW PERFORMED ON 20 NOVEMBER 2023: GMK-PRIMARY 02.07.0217SF TIBIAL INSERT STD FIXED SIZE 2 / 17 MM (K090988) LOT. 101410 LOT 101410: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 09-JUN-2010. EXPIRATION DATE: 2015-04-30. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED CASE DURING THE PERIOD OF REVIEW. GMK-PRIMARY 02.07.1202R TIBIAL TRAY FIXED CEMENTED SIZE 2 R (K090988) LOT. 112613 LOT 112613: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 18-OCT-2011. EXPIRATION DATE: 2016-09-30. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, ALL ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED CASE DURING THE PERIOD OF REVIEW.
AT ABOUT 11 YEARS AND 9 MONTHS AFTER PRIMARY, THE PATIENT CAME IN REPORTING INSTABILITY DUE TO LAXITY. THE SURGEON REVISED THE GMK PRIMARY FEMORAL COMPONENT, INSERT AND TIBIAL TRAY AND CONVERTED THE PATIENT TO A HINGE KNEE AND THE CASE WAS COMPLETED SUCCESSFULLY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1086028 | GMK-PRIMARY FEMUR STD CEMENTED SIZE 3 R | CEMENTED FEMUR | JWH | MEDACTA INTERNATIONAL SA | 111212 | 07630040720243 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Female | Required Intervention |